Overview

To Study the Efficacy & Safety of Oral NA-921 (Bionetide) in Girls and Women with Rett Syndrome

Status:
COMPLETED
Trial end date:
2025-01-28
Target enrollment:
Participant gender:
Summary
To study the efficacy \& safety of oral Bionetide versus placebo in girls and women with Rett syndrome
Phase:
PHASE2
Details
Lead Sponsor:
Biomed Industries, Inc.